Show simple item record

dc.contributor.authorFernández-Vega B.
dc.contributor.authorGonzález-Iglesias H.
dc.contributor.authorVega J.A.
dc.contributor.authorNicieza J.
dc.contributor.authorFernández-Vega Á.
dc.date.accessioned2020-09-02T22:17:31Z
dc.date.available2020-09-02T22:17:31Z
dc.date.issued2019
dc.identifier10.1016/j.ajoc.2018.12.008
dc.identifier.citation13, , 70-75
dc.identifier.issn24519936
dc.identifier.urihttps://hdl.handle.net/20.500.12728/4463
dc.descriptionPurpose: To report the clinical findings and management of a case of occipital lobe infarction with homonymous quadrantanopia in a patient treated with vitamins and coenzyme Q10. Observations: A currently 69-years-old patient presenting in 2007 left inferior quadrantanopia following a right occipital lobe stroke with initial visual field index of 82% and 79% in the right and left eyes, respectively. From 2007 to 2010 was treated with vitamin and antioxidant complexes, without specific signs of changes observed in the visual field (81% right eye, 79% left eye). In 2011 was treated for the first time with coenzyme Q10 (Active complex® Q10 Gold 100 mg) in addition to the vitamin and antioxidant supplementation. A promptly slight improvement of the visual field in both eyes was observed. In 2013, a remarkable improvement was noticed observing a slight scotoma where previously presented the quadrantanopia. Thereafter, in the successive one-year follow-up examinations the patient experienced an exponential improvement in the visual field with gradually fading of the scotoma. Currently the patient no longer presents any sign of quadrantanopia, with normal visual field in both eyes (99% right eye, 98% left eye). Conclusion and importance: Spontaneous improvement more than 6 months after stroke is thought to be unlikely. However, we observed, for the first time, an amelioration of the visual field after 10 years of an occipital lobe stroke. The combination of vitamins and coenzyme Q10 (100 mg) improved the prognosis with significant recovery of the visual field, which is impossible to recover under current knowledge. © 2018 The Authors
dc.language.isoen
dc.publisherElsevier Inc
dc.subjectCoenzyme Q10
dc.subjectHomonymous quadrantanopia
dc.subjectOccipital lobe
dc.subjectStroke
dc.subjectVitamins
dc.subjectacetylsalicylic acid
dc.subjectactive complex q10 gold
dc.subjectadiro 300
dc.subjectantioxidant
dc.subjectfolic acid
dc.subjecthidroxil
dc.subjectubidecarenone
dc.subjectvisan
dc.subjectvitamin
dc.subjectvitamin B complex
dc.subjectaged
dc.subjectArticle
dc.subjectbrain infarction
dc.subjectbrain ischemia
dc.subjectcase report
dc.subjectcerebrovascular accident
dc.subjectclinical article
dc.subjectconvalescence
dc.subjectdrug effect
dc.subjectfollow up
dc.subjecthomonymous quadrantanopia
dc.subjecthuman
dc.subjectmale
dc.subjectoccipital lobe
dc.subjectperimetry
dc.subjectscotoma
dc.subjectvisual field
dc.subjectvisual field defect
dc.subjectvitamin supplementation
dc.titleCoenzyme Q10 treatment improved visual field after homonymous quadrantanopia caused by occipital lobe infarction
dc.typeArticle


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record